Evidence map›Paper›PMID 41007506›Full record

ReviewInternational journal of environmental research and public health2025

Long COVID Symptom Management Through Self-Care and Nonprescription Treatment Options: A Narrative Review.

Preeti Kachroo, Guy Boivin, Benjamin J Cowling, Will Shannon, Pascal Mallefet, Pranab Kalita, Alexandru M Georgescu

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Preeti KachrooGlobal Category Medical Affairs, Haleon Plc., 1260 Nyon, Switzerland.ORCID 0000-0003-1058-4962
Guy BoivinDepartment of Pediatric, Faculty of Medicine, Laval University, Quebec, QC G1V 0A6, Canada.ORCID 0000-0003-3027-4662
Benjamin J CowlingSchool of Public Health, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Will ShannonPinnacle Health Clinic, North Parramatta, NSW 2151, Australia.ORCID 0009-0002-1254-0269
Pascal MallefetGlobal Category Medical Affairs, Haleon Plc., 1260 Nyon, Switzerland.
Pranab KalitaGlobal Category Medical Affairs, Haleon Plc., London KT13 0NY, UK.
Alexandru M GeorgescuGlobal Category Medical Affairs, Haleon Plc., 1260 Nyon, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many patients experience unique or persistent symptoms several months following the onset of infection with severe acute respiratory syndrome coronavirus 2, the causative agent of COVID-19. While this condition is commonly referred to as long COVID, no universally accepted definition exists; therefore, many patients go underrecognized and underreported. Long COVID can involve almost any major organ system and is characterized by widely heterogeneous persistent or recurrent symptoms including fatigue, headache, cough, dyspnea, chest pain, cognitive dysfunction, anxiety, and depression. In line with the wide array of symptoms, numerous potential underlying pathophysiologic pathways, including viral persistence, prolonged inflammation, autoimmune reactions, endothelial dysfunction, and dysbiosis of the microbiome of the gut, may contribute to the symptomology of long COVID. Therapy is directed at symptomatic control; however, no pharmacologic treatments are specifically approved for the management of symptoms associated with long COVID. Several common symptoms of long COVID may be managed with nonprescription treatments (pharmacologic and nonpharmacologic). The goal of this review is to provide clinicians with a better understanding of long COVID and review the latest recommendations for managing common mild-to-moderate symptoms with nonprescription treatment options.

Indexed as

COVID-19Self CareHumansPost-Acute COVID-19 SyndromeSARS-CoV-2burden of illnesscomplementary therapiesconservative therapieslong COVIDnonprescription drugover-the-counter drugpost-acute sequelae of COVID-19post-COVID conditionself-care

Identifiers

PMID41007506
PMCPMC12469580

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.